Stocks360

Berli Jucker Public Company Limited (BLJZY)

Stock analysis · OTC · Industrials · Conglomerates

Share: Facebook X WhatsApp SMS
$6.40

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$2.56B
PE (TTM)
13.49
EPS (TTM)
N/A
Dividend Yield
2.69%
Beta
0.20
Day Range
$6.40 – $9.64
52-wk Range
$6.40 – $9.64
Avg Volume
N/A
Volume
200.00

Berli Jucker Public Company Limited (BLJZY) is a publicly traded company in the Industrials sector. Latest price: $6.40. Market cap $2.56B. Trailing PE 13.49. Dividend yield 2.69%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $6.40 2026-10-26 · $6.40 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Berli Jucker Public Company Limited

Berli Jucker Public Company Limited (BJC), founded in 1882 and based in Bangkok, Thailand, operates as a subsidiary of TCC Corporation Company Limited. This diverse conglomerate is actively involved in the production, distribution, and service provision across a multitude of industries within Thailand. BJC's primary business activities encompass: Packaging Solutions: The company is engaged in the creation, manufacturing, and supply of various packaging types, including glass and plastic containers, as well as aluminum cans. Consumer Goods: BJC distributes a wide range of products for everyday use, such as personal care items, household necessities, and office stationery and supplies. Its food product portfolio includes snacks, beverages, processed fruits, and dairy products like milk and yogurt. Healthcare and Technical Products: Within the healthcare sector, BJC is a key importer and distributor of a comprehensive selection of pharmaceuticals, medical provisions, cosmeceuticals, nutritional supplements, and general health-related items. This vast array covers treatments for numerous conditions in areas such as nephrology, hematology, cardiology, endocrine disorders, oncology, gen…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)13.49×
P/S (TTM)0.50×
P/B0.67×
PEG0.43×
P/FCF (TTM)9.00×
EV / EBITDA16.45×
EV / Sales1.57×
Earnings Yield7.43%
Free Cash Flow Yield11.11%
Dividend Yield2.69%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$249.82B
Revenue (TTM)$158.90B
Net Income (TTM)$5.87B
Free Cash Flow (TTM)$12.94B
Net Debt$170.87B
Working Capital-$32.82B
Gross Margin20.51%
Operating Margin1.14%
Net Margin3.69%
Return on Equity4.90%
Return on Invested Capital0.46%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap